Cargando…
Diabetes medications and associations with Covid-19 outcomes in the N3C database: A national retrospective cohort study
BACKGROUND: While vaccination is the most important way to combat the SARS-CoV-2 pandemic, there may still be a need for early outpatient treatment that is safe, inexpensive, and currently widely available in parts of the world that do not have access to the vaccine. There are in-silico, in-vitro, a...
Autores principales: | Bramante, Carolyn T., Johnson, Steven G., Garcia, Victor, Evans, Michael D., Harper, Jeremy, Wilkins, Kenneth J., Huling, Jared D., Mehta, Hemalkumar, Alexander, Caleb, Tronieri, Jena, Hong, Stephenie, Kahkoska, Anna, Alamgir, Joy, Koraishy, Farrukh, Hartman, Katrina, Yang, Kaifeng, Abrahamsen, Trine, Stürmer, Til, Buse, John B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671347/ https://www.ncbi.nlm.nih.gov/pubmed/36395143 http://dx.doi.org/10.1371/journal.pone.0271574 |
Ejemplares similares
-
Are fewer cases of diabetes mellitus diagnosed in the months after SARS-CoV-2 infection?: A population level view in the EHR-based RECOVER program
por: Reddy, Neha V, et al.
Publicado: (2022) -
Are fewer cases of diabetes mellitus diagnosed in the months after SARS-CoV-2 infection? A population-level view in the EHR-based RECOVER program
por: Reddy, Neha V., et al.
Publicado: (2023) -
Effect of SARS-CoV-2 Infection and Infection Severity on Longer-Term Glycemic Control and Weight in People With Type 2 Diabetes
por: Wong, Rachel, et al.
Publicado: (2022) -
Association Between Glucagon-Like Peptide 1 Receptor Agonist and Sodium–Glucose Cotransporter 2 Inhibitor Use and COVID-19 Outcomes
por: Kahkoska, Anna R., et al.
Publicado: (2021) -
Deintensification of Treatment With Sulfonylurea and Insulin After Severe Hypoglycemia Among Older Adults With Diabetes
por: Alexopoulos, Anastasia-Stefania, et al.
Publicado: (2021)